Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,418,349 papers from all fields of science
Search
Sign In
Create Free Account
GSK 1363089
Known as:
GSK1363089
, GSK-1363089
, Multitargeted Tyrosine Kinase Inhibitor GSK1363089
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (2)
Anilides
Quinolines
Narrower (3)
EXEL 2880
XL880
foretinib
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Cancer Therapy : Preclinical Foretinib ( GSK 1363089 ) , an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2 , Blocks Proliferation , Induces Anoikis , and Impairs Ovarian Cancer…
M. Zillhardt
,
Sun-Mi Park
,
+6 authors
E. Lengyel
2011
Corpus ID: 27113116
Purpose:Currently, there are no approved targeted therapies for the treatment of ovarian cancer, despite the fact that it is the…
Expand